Medical Products Laboratories, Inc
Form 483 issued July 13, 2023 · Philadelphia, Pennsylvania
- Inspection
- Jun 28 – Jul 13, 2023
- Investigator
- Daniel J. Min
- Observations
- 1
- Pages
- 2
- FEI number
- 2513595
In short: On July 13, 2023, FDA issued a Form 483 with 1 observation to Medical Products Laboratories, Inc in Philadelphia, Pennsylvania (FEI 2513595) after an inspection that ran Jun 28 – Jul 13, 2023. The investigator was Daniel J. Min. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.63 (equipment design, size, and location).
At a glance
1 of 1 observations on this 483 concern facilities & equipment.
Most cited: 21 CFR 211.63 (1×)
What FDA observed
Preview: the opening words of each observation- 01
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…
This inspection in context
Daniel J. Min
8 documents · 2021–2023
Cites FDCA 501(a)(2)(A) (insanitary conditions) more than any other section. Most of their documents are for sites in Pennsylvania.
The firmMedical Products Laboratories, Inc history
All 5 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.63
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Medical Products Laboratories, Inc?
FDA listed 1 observation on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.63 (equipment design, size, and location). The opening words of each observation are shown on this page.
Who inspected Medical Products Laboratories, Inc?
Daniel J. Min is named on this Form 483, for the inspection of Jun 28 – Jul 13, 2023. Each investigator has a profile showing what they cite most.
When was Medical Products Laboratories, Inc inspected by FDA?
The inspection ran Jun 28 – Jul 13, 2023, and the Form 483 is dated July 13, 2023.
How do I get the full Form 483 for Medical Products Laboratories, Inc?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.